相关实验视频

Updated: Mar 6, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

通过孟德尔随机化分析选的神经母细胞瘤的潜在治疗标

Zhenge Yang^1,2, Yunlong Zhang^1,2, Shan Wang^1,2

¹Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University; National Clinical Research Center for Children and Adolescents' Health and Diseases; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.

Archives of Iranian medicine

|March 4, 2026

概括

这项研究在上腺体和血液中确定了影响神经母细胞瘤 (NB) 风险的基因. 免疫细胞在血液基因通路中至关重要,突出显示了儿童癌症的潜在治疗点.

科学领域:

遗传学是一个遗传学.
在瘤学瘤学.
流行病学流行病学

背景情况:

神经母细胞瘤 (NB) 是最常见的儿童脑外固体瘤.
迫切需要改进治疗策略,以改善患者的预后.

研究的目的:

调查上腺和血液相关基因与NB风险之间的因果关系.
为了确定神经母细胞瘤的潜在治疗点.

主要方法:

使用两样双向门德尔随机化 (MR) 与大规模遗传数据集.
集成的上腺和血液表达定量特征位置 (eQTL) 数据.
进行了局部化分析,以确定共享的遗传影响.

主要成果:

确定了与NB风险相关的8个上腺基因,其中5个显示降低风险,3个显示在上调时增加风险.
发现了43个与血液相关的基因,通过影响54种免疫细胞表型,影响NB.
八个基因显示与七个免疫细胞共定位,表明潜在的治疗作用.

结论:

上腺和血液中的特定基因会影响NB的发育.
免疫细胞在NB途径中发挥着重要作用,受血液基因的影响.
MR 和局部化分析有效地优先考虑NB治疗的候选基因.

关键词:

门德尔的随机化 (MR)神经母细胞瘤 (NB) 是一个治疗目标治疗目标

更多相关视频

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...